糖尿病与南部印度群体的口腔并发症有关
Manisha K1, Vishnu Priya Veeraraghavan1, Kaviyarasi Renu1
1Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India, 600 077.
Bioinformation
|September 18, 2023
概括
这项研究通过分析生化指标,将牙健康与糖尿病联系起来. 患有口腔问题的糖尿病患者表现出血糖和HbA1c水平升高,证实了这种联系.
科学领域:
- 生物化学 生物化学
- 口腔医学是指口腔医学.
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病是一种代谢障碍,以高血糖和胰岛素抵抗为标志.
- 控制不良的糖尿病会导致各种全身和口腔健康并发症.
- 评估生化标志物对于了解糖尿病和口腔健康之间的相互作用至关重要.
研究的目的:
- 评估用于评估糖尿病患者口腔健康的生物化学指标.
- 通过自动化分析,研究血糖控制和口腔条件之间的相关性.
- 建立牙状况和糖尿病管理之间的联系.
主要方法:
- 使用全自动生化分析仪进行血清分离和分析.
- 随机测量血糖 (RBS),血红蛋白A1c (HbA1c),禁食血糖 (FBS) 和食后血糖 (PBS) 的数据.
- 糖尿病患者的生物化学概况与口腔并发症和没有口腔并发症的比较.
主要成果:
- 患有口腔复杂问题的糖尿病患者表现出明显更高的RBS,HbA1c,FBS和PBSS.
- 在牙健康受损的患者中观察到关键血糖指标的水平升高.
- 发现糖尿病指标的严重程度与口腔健康状况之间存在明显的关联.
结论:
- 牙状况被证明与糖尿病有关.
- 血液标记物的生物化学分析可以帮助评估糖尿病患者的口腔健康.
- 有效的糖尿病管理可能会对口腔健康结果产生积极影响.
更多相关视频
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
581
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
581
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes
980
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
980
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
230
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
230
Oral Hypoglycemic Agents: Sulfonylureas
235
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
235


